Skip to main content
. 2021 Jan 28;60(10):4568–4580. doi: 10.1093/rheumatology/keab047

Fig. 3.

Fig. 3

sIL-6R concentration-time profiles with s.c.-TCZ treatment of TCZ-prior (A, B) and TCZ-naive (C, D) patients

Data are shown as median (IQR) values. Error bars = IQR. BW: body weight; IQR: interquartile range; Q10D: every 10 days; QW: every week; Q2W: every 2 weeks; Q3W: every 3 weeks; sIL-6R: serum IL-6 receptor; TCZ: tocilizumab.